Patents by Inventor John Ziqi Jiang

John Ziqi Jiang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS AS MODULATORS OF BIS-PHOSPHOGLYCERATE MUTASE FOR THE TREATMENT OF SICKLE CELL DISEASE
    Publication number: 20230348454
    Abstract: Provided herein are compounds and compositions thereof for modulating bis-phosphoglycerate mutase (BPGM) for treating sickle cell disease.
    Type: Application
    Filed: September 14, 2021
    Publication date: November 2, 2023
    Inventors: Kunal Desai, Zhong Fang, Kevin Guertin, Vu Hong, John Ziqi Jiang, Sungtaek Lim, Jinyu Liu, Mark Munson
  • CARBOXYLIC ACID-CONTAINING COMPOUNDS AS MODULATORS OF BIS-PHOSPHOGLYCERATE MUTASE FOR THE TREATMENT OF SICKLE CELL DISEASE
    Publication number: 20230348450
    Abstract: Provided herein are compounds and compositions thereof for modulating bis-phosphoglycerate mutase (BPGM) for treating sickle cell disease.
    Type: Application
    Filed: September 14, 2021
    Publication date: November 2, 2023
    Inventors: Kunal Desai, Zhong Fang, Kevin Guertin, Vu Hong, John Ziqi Jiang, Sungtaek Lim, Mark Munson
  • Pyrimidine amide compounds as PGDS inhibitors
    Patent number: 8202863
    Abstract: This invention is directed to a compound of formula (I): wherein R1, R2, R3 and L1 are as defined herein, a pharmaceutical composition comprising the compound, and the use of the compound to treat allergic and/or inflammatory disorders, particularly disorders such as allergic rhinitis, asthma and/or chronic obstructive pulmonary disease (COPD).
    Type: Grant
    Filed: April 4, 2008
    Date of Patent: June 19, 2012
    Assignee: Aventis Pharmaceuticals Inc.
    Inventors: Suzanne C. Aldous, John Ziqi Jiang, Jinqi Lu, Liang Ma, Lan Mu, Harry Randall Munson, Jeffrey Stephen Sabol, Sukanthini Thurairatnam, Christopher Loren Vandeusen
  • Substituted AZA-indoles as inhibitors of poly(ADP-ribose) polymerase (PARP)
    Patent number: 8008491
    Abstract: The present invention relates to a series of substituted aza-indole derivatives of the formula I: wherein R, R1, R2, R3, R4, X and Y are as defined herein. This invention also relates to methods of making these compounds. The compounds of this invention are inhibitors of poly(adenosine 5?-diphosphate ribose) polymerase (PARP) and are therefore useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of diseases, including diseases associated with the central nervous system and cardiovascular disorders.
    Type: Grant
    Filed: June 17, 2008
    Date of Patent: August 30, 2011
    Assignee: Aventis Pharmaceuticals, Inc.
    Inventors: John Ziqi Jiang, Jack Roger Koehl, Shujaath Mehdi, Neil Moorcroft, Kwon Yon Musick, Philip Marvin Weintraub, Paul Robert Eastwood
  • PYRIMIDINE AMIDE COMPOUNDS AS PGDS INHIBITORS
    Publication number: 20080227782
    Abstract: This invention is directed to a compound of formula (I): wherein R1, R2, R3 and L1 are as defined herein, a pharmaceutical composition comprising the compound, and the use of the compound to treat allergic and/or inflammatory disorders, particularly disorders such as allergic rhinitis, asthma and/or chronic obstructive pulmonary disease (COPD).
    Type: Application
    Filed: April 4, 2008
    Publication date: September 18, 2008
    Applicant: AVENTIS PHARMACEUTICALS INC
    Inventors: Suzanne C. Aldous, John Ziqi Jiang, Jinqi Lu, Liang Ma, Lan Mu, Harry Randall Munson, Jeffrey Stephen Sabol, Sukanthini Thurairatnam, Christopher Loren Vandeusen